Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer

<p>supplemental tables 5-7</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Junko Tsuji (15051410) (author)
Autres auteurs:	Tianyu Li (15050574) (author), Albert Grinshpun (15051413) (author), Tim Coorens (15051416) (author), Douglas Russo (15051419) (author), Leilani Anderson (15051422) (author), Rebecca Rees (15051425) (author), Agostina Nardone (14958879) (author), Candace Patterson (15051428) (author), Niall J. Lennon (15051431) (author), Carrie Cibulskis (15051434) (author), Ignaty Leshchiner (15051437) (author), Nabihah Tayob (15029789) (author), Sara M. Tolaney (15051440) (author), Nadine Tung (15051443) (author), Donald P. McDonnell (15051446) (author), Ian E. Krop (15029231) (author), Eric P. Winer (14958942) (author), Chip Stewart (15021003) (author), Gad Getz (14945542) (author), Rinath Jeselsohn (14948026) (author)
Publié:	2025
Sujets:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Breast Cancer Drug Targets Genome Biology Tumor Evolution Tumor Heterogeneity
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
par: Juliana Navarro-Yepes (17079059)
Publié: (2025)

2- Exome sequencing of sample tumor tissue 1- Exome sequencing of sample matched normal tissue
par: Hossein Khanahmad (21998459)
Publié: (2025)

Supplementary Tables from Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells
par: Francesco Maura (15022226)
Publié: (2025)

Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
par: Francisco Hermida-Prado (14958909)
Publié: (2025)

Suppl Data 2 from Whole Slide Imaging-Based Prediction of <i>TP53</i> Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
par: Marija Pizurica (17060224)
Publié: (2025)

Suppl. Data 1 from Whole Slide Imaging-Based Prediction of <i>TP53</i> Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
par: Marija Pizurica (17060224)
Publié: (2025)

Supplementary Movie 1 from The Macrophage-Associated LncRNA <i>MALR</i> Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer
par: Jia Liu (15386858)
Publié: (2025)

Classification of Udai21 and the World Rice Core Collection based on whole genome sequencing data.
par: Hiroki Ikeda (510280)
Publié: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
par: Francesca Orzan (15055579)
Publié: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
par: Francesca Orzan (15055579)
Publié: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
par: Francesca Orzan (15055579)
Publié: (2025)

Supplementary Data S1 from Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer
par: Andrew A. Davis (15030032)
Publié: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
par: Hailong Pang (12841991)
Publié: (2025)

Data Sheet 2_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
par: Hailong Pang (12841991)
Publié: (2025)

Data Sheet 1_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
par: Hailong Pang (12841991)
Publié: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
par: Lavanya Sivapalan (15314248)
Publié: (2025)

Supplementary Table 1_Primer and shRNA sequences_PCR cycles_Mycoplasma testing from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
par: Niccolò Roda (16437288)
Publié: (2025)

Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
par: Tom Wei-Wu Chen (15053003)
Publié: (2025)

Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
par: Tom Wei-Wu Chen (15053003)
Publié: (2025)

Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
par: Tom Wei-Wu Chen (15053003)
Publié: (2025)

Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
par: Tom Wei-Wu Chen (15053003)
Publié: (2025)

Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
par: Tom Wei-Wu Chen (15053003)
Publié: (2025)

Data Sheet 1_Whole genome sequencing as a reliable alternative for Salmonella serotyping: a comparative study with the gold-standard method.pdf
par: Irene Mileto (20877575)
Publié: (2025)

Supplementary Figure S1 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
par: Kala Visvanathan (14952973)
Publié: (2025)

Supplementary Figure S2 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
par: Kala Visvanathan (14952973)
Publié: (2025)

Supplementary Figure S3 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
par: Kala Visvanathan (14952973)
Publié: (2025)

Supplementary Figure S4 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
par: Kala Visvanathan (14952973)
Publié: (2025)

Supplementary Figure S5 from Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial
par: Kala Visvanathan (14952973)
Publié: (2025)

Table S1 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
par: Hanyun Zhang (15386757)
Publié: (2025)

Table S2 from Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma
par: Hanyun Zhang (15386757)
Publié: (2025)

Supplementary Table 10_Pro metastatic pathways identified by classification analysis from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
par: Niccolò Roda (16437288)
Publié: (2025)

Supplementary Table 2_Predictive power of genes and signatures_Patient cohorts GEO accession number from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
par: Niccolò Roda (16437288)
Publié: (2025)

Supplementary Table 3_Clonal distribution analysis from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
par: Niccolò Roda (16437288)
Publié: (2025)

Supplementary Table 4_Marker genes all and some per cluster_GO and curated pathways per cluster from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
par: Niccolò Roda (16437288)
Publié: (2025)

Supplementary Table 5_Marker genes all and some per cluster no cell cycle_GO and curated pathways per cluster no cell cycle from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
par: Niccolò Roda (16437288)
Publié: (2025)

Supplementary Table 6_Gene modules analysis_GO and curated pathways associated to gene modules from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
par: Niccolò Roda (16437288)
Publié: (2025)

Supplementary Table 7_Genes identified by differential expression analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
par: Niccolò Roda (16437288)
Publié: (2025)

Supplementary Table 8_Genes identified by classification analysis in pro vs non metastatic clones from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
par: Niccolò Roda (16437288)
Publié: (2025)

Supplementary Table 9_Pro metastatic pathways identified by differential expression singlePT setting from A Rare Subset of Primary Tumor Cells with Concomitant Hyperactivation of Extracellular Matrix Remodeling and dsRNA-IFN1 Signaling Metastasizes in Breast Cancer
par: Niccolò Roda (16437288)
Publié: (2025)

Table S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
par: Bahar Rastegar (16031079)
Publié: (2025)

Cannot write session to /tmp/vufind_sessions/sess_dh68s1apjrcmojhi8vukb3fgp5